CoChat

p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2–Induced Type 1 Collagen Production in Trabecular Meshwork Cells

Open access

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Glaucoma is an age-related neurodegenerative disease of retinal ganglion cells, and appropriate turnover of the extracellular matrix in the trabecular meshwork is important in its pathology. Here, we report the effects of Rho-associated kinase (ROCK) and p38 MAP kinase on transforming growth factor (TGF)-β2-induced type I collagen production in human trabecular meshwork cells. TGF-β2 increased RhoA activity, actin polymerization, and myosin light chain 2 phosphorylation. These effects were significantly inhibited by Y-27632, but not SB203580. TGF-β2 also increased promoter activity, mRNA synthesis, and protein expression of COL1A2. These effects were significantly inhibited by SB203580, but not Y-27632. Additionally, Y-27632 did not significantly inhibit TGF-β2-induced promoter activation, or phosphorylation or nuclear translocation of Smad2/3, whereas SB203580 partially suppressed these processes. Collectively, TGF-β2-induced production of type 1 collagen is suppressed by p38 inhibition and accompanied by partial inactivation of Smad2/3, in human trabecular meshwork cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0120774

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Analysis of the Rho signaling activity. (A) Effect of TGF-β2 on RhoA activity in HTM cells. (B) Effects of TGF-β2, Y-27632 and SB203580 on myosin light chain (MLC)-2 phosphorylation in HTM cells. Cells with or without 10 μM Y-27632 or 10 μM SB203580 pretreatment for 30 min were stimulated with 2.5 ng/ml TGF-β2 for 30 min. Data shown in upper panels are results of representative Western blot analyses of phosphorylated MLC2 (pMLC2) and total MLC2. Relative changes in the ratio of MLC phosphorylation are shown in the lower graph. Data are shown as means ± SE, n = 10. *P < 0.05 and **P < 0.01 calculated using the Tukey—Kramer HSD test.
Fig 1 Analysis of the Rho signaling activity. (A) Effect of TGF-β2 on RhoA activity in HTM cells. (B) Effects of TGF-β2, Y-27632 and SB203580 on myosin light chain (MLC)-2 phosphorylation in HTM cells. Cells with or without 10 μM Y-27632 or 10 μM SB203580 pretreatment for 30 min were stimulated with 2.5 ng/ml TGF-β2 for 30 min. Data shown in upper panels are results of representative Western blot analyses of phosphorylated MLC2 (pMLC2) and total MLC2. Relative changes in the ratio of MLC phosphorylation are shown in the lower graph. Data are shown as means ± SE, n = 10. *P < 0.05 and **P < 0.01 calculated using the Tukey—Kramer HSD test.CC BY · PubMed Central
Fig 2 Effects of TGF-β2, Y-27632 and SB203580 on actin stress fibers in HTM cells. HTM cells were pretreated with 10 μM Y-27632 (B, E) or 10 μM SB203580 (C, F) for 30 min, and then stimulated with 2.5 ng/ml TGF-β2 (D-F) for 24 h, stained with phalloidin-FITC, and observed by fluorescence microscopy. Scale bar: 50 μm.
Fig 2 Effects of TGF-β2, Y-27632 and SB203580 on actin stress fibers in HTM cells. HTM cells were pretreated with 10 μM Y-27632 (B, E) or 10 μM SB203580 (C, F) for 30 min, and then stimulated with 2.5 ng/ml TGF-β2 (D-F) for 24 h, stained with phalloidin-FITC, and observed by fluorescence microscopy. Scale bar: 50 μm.CC BY · PubMed Central
Fig 3 Effects of TGF-β2, Y-27632 and SB203580 on COL1A2 induction in HTM cells. HTM cells were pretreated with 10 μM Y-27632 or 10 μM SB203580 for 30 min, and then stimulated with 2.5 ng/ml TGF-β2 for 24 h. Data are shown as means ± SE. *P < 0.05 and **P < 0.01 calculated using the Tukey—Kramer HSD test. (A) Effects of TGF-β2, Y-27632 and SB203580 on COL1A2 promoter activity. Signals from a plasmid containing Renilla luciferase were used as an internal control. n = 15. (B, C) Effects of TGF-β2, Y-27632 and SB203580 on COL1A2 and Fibronectin mRNA transcription, respectively. Relative expression levels of the genes were compared, using the comparative CT method. β-glucuronidase was used as a control. Relative signals from a luciferase reporter gene fused with 436 bp were compared. n = 6, each. (D) Effects of TGF-β2, Y-27632 and SB203580 on COL1A2 protein expression in HTM cells. Data shown in upper panels are results of representative Western blot analyses. Relative changes to β-actin are shown in the lower graph. n = 9.
Fig 3 Effects of TGF-β2, Y-27632 and SB203580 on COL1A2 induction in HTM cells. HTM cells were pretreated with 10 μM Y-27632 or 10 μM SB203580 for 30 min, and then stimulated with 2.5 ng/ml TGF-β2 for 24 h. Data are shown as means ± SE. *P < 0.05 and **P < 0.01 calculated using the Tukey—Kramer HSD test. (A) Effects of TGF-β2, Y-27632 and SB203580 on COL1A2 promoter activity. Signals from a plasmid containing Renilla luciferase were used as an internal control. n = 15. (B, C) Effects of TGF-β2, Y-27632 and SB203580 on COL1A2 and Fibronectin mRNA transcription, respectively. Relative expression levels of the genes were compared, using the comparative CT method. β-glucuronidase was used as a control. Relative signals from a luciferase reporter gene fused with 436 bp were compared. n = 6, each. (D) Effects of TGF-β2, Y-27632 and SB203580 on COL1A2 protein expression in HTM cells. Data shown in upper panels are results of representative Western blot analyses. Relative changes to β-actin are shown in the lower graph. n = 9.CC BY · PubMed Central
Fig 4 Effects of TGF-β2, Y-27632 and SB203580 on phosphorylation of Smad2 in HTM cells. HTM cells were pretreated with 10 μM Y-27632 (A) or 10 μM SB203580 (B) for 30 min, and then stimulated with 2.5 ng/ml TGF-β2 for 24 h. Data shown in upper panels are results of representative Western blot analyses of phosphorylated Smad2 (pSmad2) and total Smad2/3. Relative changes in the pSmad2 to total Smad2 expression level are shown in the lower graph. Data are shown as means ± SE, n = 6. **P < 0.01 compared with control using the Tukey—Kramer HSD test.
Fig 4 Effects of TGF-β2, Y-27632 and SB203580 on phosphorylation of Smad2 in HTM cells. HTM cells were pretreated with 10 μM Y-27632 (A) or 10 μM SB203580 (B) for 30 min, and then stimulated with 2.5 ng/ml TGF-β2 for 24 h. Data shown in upper panels are results of representative Western blot analyses of phosphorylated Smad2 (pSmad2) and total Smad2/3. Relative changes in the pSmad2 to total Smad2 expression level are shown in the lower graph. Data are shown as means ± SE, n = 6. **P < 0.01 compared with control using the Tukey—Kramer HSD test.CC BY · PubMed Central
Fig 5 Effects of TGF-β2, Y-27632 and SB203580 on nuclear translocation of Smad2/3 in HTM cells. HTM cells were pretreated with 10 μM Y-27632 (B, E) or 10 μM SB203580 (C, F) for 30 min, and then stimulated with 2.5 ng/ml TGF-β2 (D-F) for 24 h, immunolabeled with anti-Smad2/3 antibody (red), and observed by fluorescence microscopy. Cell nuclei were counterstained by DAPI (blue). Scale bar: 50 μm. (G) Relative expressions of nucleic Smad2 to its cytoplasmic expression are shown in the graph. Nucleic and cytoplasmic proteins were extracted, and the expression level of Smad2 was assessed separately. Data are shown as means ± SE, n = 5.
Fig 5 Effects of TGF-β2, Y-27632 and SB203580 on nuclear translocation of Smad2/3 in HTM cells. HTM cells were pretreated with 10 μM Y-27632 (B, E) or 10 μM SB203580 (C, F) for 30 min, and then stimulated with 2.5 ng/ml TGF-β2 (D-F) for 24 h, immunolabeled with anti-Smad2/3 antibody (red), and observed by fluorescence microscopy. Cell nuclei were counterstained by DAPI (blue). Scale bar: 50 μm. (G) Relative expressions of nucleic Smad2 to its cytoplasmic expression are shown in the graph. Nucleic and cytoplasmic proteins were extracted, and the expression level of Smad2 was assessed separately. Data are shown as means ± SE, n = 5.CC BY · PubMed Central
Fig 6 Effects of TGF-β2, Y-27632 and SB203580 on transactivation of Smad complexes in HTM cells. HTM cells were pretreated with 10 μM Y-27632 or 10 μM SB203580 for 30 min, and then stimulated with 2.5 ng/ml TGF-β2 for 24 h. Relative signals from a luciferase reporter gene fused with 12 repeats of the Smad-complex binding element (CAGA) were compared among samples. Signals from a plasmid containing Renilla luciferase were used as an internal control. Data are shown as means ± SE, n = 9. *P < 0.05 and **P < 0.01 calculated using the Tukey—Kramer HSD test.
Fig 6 Effects of TGF-β2, Y-27632 and SB203580 on transactivation of Smad complexes in HTM cells. HTM cells were pretreated with 10 μM Y-27632 or 10 μM SB203580 for 30 min, and then stimulated with 2.5 ng/ml TGF-β2 for 24 h. Relative signals from a luciferase reporter gene fused with 12 repeats of the Smad-complex binding element (CAGA) were compared among samples. Signals from a plasmid containing Renilla luciferase were used as an internal control. Data are shown as means ± SE, n = 9. *P < 0.05 and **P < 0.01 calculated using the Tukey—Kramer HSD test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 36

Metadata

Authors
Inoue-Mochita, M., Inoue, T., Fujimoto, T., Kameda, T., Awai-Kasaoka, N., Ohtsu, N., Kimoto, K., & Tanihara, H.
Affiliations
  • Kumamoto University (JP)
  • Kyoto University (JP)
  • Oita University (JP)
Corresponding author
Inoue, Toshihiro
Venue
PLOS ONE
Published
2015-03-23
Volume
10
Issue
3
Pages
e0120774
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2135038084
Cited by
34
References
34
Citations by year
2026: 1 · 2025: 5 · 2024: 2 · 2023: 8 · 2022: 1 · 2021: 6 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 2
FWCI
2.88
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Japan Society for the Promotion of Science (25861640, 23390403, 23791994)
Topics
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
p38 MAPK, Rho kinase, TGF-beta2, type I collagen, trabecular meshwork cells, glaucoma, extracellular matrix turnover, RhoA, actin polymerization, myosin light chain 2 phosphorylation, Smad2/3, COL1A2, Y-27632, SB203580
MeSH terms
Cell Line, Humans, Phosphorylation, Protein Binding, Trabecular Meshwork, Signal Transduction, Myosin Light Chains, Collagen Type I, Cardiac Myosins, Protein Kinase Inhibitors, p38 Mitogen-Activated Protein Kinases, Smad Proteins, Transforming Growth Factor beta2, rho-Associated Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2–Induced Type 1 Collagen Production in Trabecular Meshwork Cells. https://app.cochat.ai/papers/10.1371/journal.pone.0120774
The paper
Inoue-Mochita, M., Inoue, T., Fujimoto, T., Kameda, T., Awai-Kasaoka, N., Ohtsu, N., Kimoto, K., & Tanihara, H. (2015). p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2–Induced Type 1 Collagen Production in Trabecular Meshwork Cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0120774

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.